• Info
  • Insider Ownership

Insider Trading & Ownership of John C. Reed

Location
New Brunswick, NJ
Summary
The estimated net worth of John C. Reed is at least $10,315,169 dollars as of 18 Feb 2026. John C. Reed is the EVP, Innovative Medicine, R&D of JOHNSON & JOHNSON and owns shares of JOHNSON & JOHNSON (JNJ) stock worth about $10.32M.
Signature
/s/ Joleen Morgan, as attorney-in-fact for John C. Reed
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow John C. Reed and return when a new Insider Trading filing appears.

This tracks SEC filing changes for this page using existing product update flows.

Sign up to save research and follow filings

Sponsored

Quick Takeaways

  • John C. Reed has 1 issuer position tracked on this page.
  • Estimated disclosed ownership value: $10,315,169.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: JOHNSON & JOHNSON ($10,315,169).
  • Past-year value change for that position: -$20,420,856.

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Official SEC Source

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of John C. Reed

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
JNJ JOHNSON & JOHNSON EVP, Innovative Medicine, R&D $10,315,169 -$20,420,856 -66% 15 Feb 2026

Insider Transactions Reported by John C. Reed:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Sponsored